Clusterin anticorps (N-Term) (APC)
Aperçu rapide pour Clusterin anticorps (N-Term) (APC) (ABIN2235180)
Antigène
Voir toutes Clusterin (CLU) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 71-99, N-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- CLU, NT (CLU, APOJ, CLI, KUB1, Clusterin, Aging-associated gene 4 protein, Apolipoprotein J, Complement cytolysis inhibitor, Complement-associated protein SP-40,40, Ku70-binding protein 1, NA1/NA2, Testosterone-repressed prostate message 2, Clusterin beta chain, ApoJalpha, Complement cytolysis inhibitor a chain, Clusterin alpha chain, ApoJbeta, Complement cytolysis inhibitor b chain) (APC)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- CLU antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 71-99 amino acids from the N-terminal region of human CLU.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2.
-
Stock
- 4 °C
-
Stockage commentaire
- 4°C ,Do Not Freeze
-
-
- Clusterin (CLU)
-
Autre désignation
- CLU
-
NCBI Accession
- NP_001164609, NP_976084
-
UniProt
- P10909
-
Pathways
- Apoptose, Negative Regulation of intrinsic apoptotic Signaling
Antigène
-